13F-HR filed by Finepoint Capital LP
Finepoint Capital LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 9 holding rows worth $2,003,633,201.
- Accession
- 0000904454-26-000098
- Filer
- CIK 1608126
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 9 entries on the cover page, a total value of $2,003,633,201 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,003,633,201 with VALUE read as dollars as filed, 13F file number 028-16580. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPY | 78462F103 | SHS | 1,573,200 | $1,072,796,544 | dollars as filed | put |
| QXO INC COM NEW | 82846H405 | Stock | 21,177,415 | $408,512,335 | dollars as filed | |
| iShares Russell 2000 ETF | 464287655 | SHS | 1,617,000 | $398,040,720 | dollars as filed | put |
| RXO, Inc. | 74982T103 | Common Stock, $0.01 par value | 9,388,789 | $118,674,293 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 961,251 | $5,421,456 | dollars as filed | |
| ALEANNA INC | 01444V103 | COM CL A | 27,717 | $78,993 | dollars as filed | |
| ALEANNA INC | 01444V111 | *W EXP 12/13/202 | 490,000 | $69,335 | dollars as filed | |
| MONEYHERO LIMITED | G6202B119 | *W EXP 09/13/202 | 895,000 | $38,306 | dollars as filed | |
| CALIDI BIOTHERAPEUTICS INC | 320703408 | COM | 1,042 | $1,219 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000904454-26-000098 | this filing | 2026-02-13 | acceptance time not in the bulk data set |